Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 1300 results for "astrazeneca"

Research and Markets: Global Endometriosis Market 2014-2018 with Abbvie Inc., AstraZeneca plc, Bayer AG & Pfizer Inc. Dominating

Technical Coverage on Pharma Stocks -- GlaxoSmithKline, Therap...

/PRNewswire/ -- On Monday, July 21, 2014, the NASDAQ Composite ended at 4,424.70, down 0.17%, the Dow Jones Industrial Average declined 0.28%, to finish the day at 17,051.73, and the S&P 500 closed at 1,973.63, down 0.23%. The losses were broad ..., 4 hours ago

2,182 images for astrazeneca

American Banking News, 2 hours ago
Building4change, 5 hours ago
Cambridge Network, 6 hours ago
Invezz, 5 hours ago
Pharmafocus, 1 day ago
Designboom, 1 day ago
Pharma Letter, 9 minutes ago
Designboom, 1 day ago
Designboom, 1 day ago
Designboom, 1 day ago
Pharma Letter

Advaxis and MedImmune team up in cancer immunotherapy

07:45 ET | About: Advaxis Inc. (ADXS) Advaxis (NASDAQ:ADXS) and AstraZeneca's (NYSE:AZN) MedImmune establish a clinical trial collaboration to evaluate the safety and efficacy of MedImmune's investigational anti-PD-L1 immune checkpoint inhibitor, ...
 Seeking Alpha5 hours ago AstraZeneca's MedImmune announces cancer immunotherapies partnership with Advaxis22-07-2014  Pharma Letter36 minutes ago AstraZeneca adds Advaxis to a growing roster of immuno-oncology partners  FierceBiotech4 hours ago MedImmune and Advaxis Partner on Immuno-Oncology Combination Clinical Trial  PharmaceuticalProcessing4 hours ago

Potential AstraZeneca (AZN) Trade Has 5.23% Downside Protection's patented algorithms have selected a trade on AstraZeneca Plc ("AZN) that returns 12.90% in 61 days for an annualized return rate of 77%. This diagonal spread pairs a ...
 Individual.com1 day ago Potential AstraZeneca (AZN) Trade Targets 4.88% Return  Individual.com5 days ago
Pharma Letter

Researchers Granted Access to Abandoned Compounds

The U.K.'s Medical Research Council (MRC) has inked a partnership with seven pharmaceutical firms—AstraZeneca, GlaxoSmithKline, Janssen Research & Development, Eli Lilly , Pfizer , Takeda , and UCB—giving U.K. researchers access to a virtual ...
 Genetic Engineering News2 hours ago Seven pharma companies offer up compounds to UK researchers [Global Data Point]  TMC Net1 hour ago Pharma firms give researchers access  Pharmafocus7 hours ago
Manufacturing Chemist

AstraZeneca reveals designs for new U.K. global R&D center, corporate headquarters

AstraZeneca revealed its proposed designs for its new global R&D center and corporate headquarters in Cambridge, U.K. The facility, which will be located on the Cambridge Biomedical Campus (CBC), includes the global center, an R&D enabling building ...
 Center Watch17 hours ago AstraZeneca`s new Global R&D Centre and Corporate Headquarters in Cambridge, UK  PharmiWeb23 hours ago AstraZeneca reveals proposed designs for new global R&D centre in Cambridge, UK  PharmaBiz3 days ago Drug firm's new HQ design revealed  BBC4 days ago

AstraZeneca to collaborate with Advaxis for cancer immunotherapy

LONDON: AstraZeneca is casting its net wider in the hot cancer immunotherapy field through a clinical trial collaboration with US biotech firm Advaxis that will test drugs from both companies in combination. Britain-based AstraZeneca, the target ...
 Economic Times10 hours ago AstraZeneca widens cancer immunotherapy net with Advaxis trial  Reuters11 hours ago

Tuesday's Top Health Care Stocks: Herbalife, Exact Sciences, AstraZeneca, J

Let's take a quick look at four stocks -- Herbalife (NYSE: HLF Herbalife investors brace for another Ackman assault Herbalife is down more than 3% in pre-market trading, During an interview on "Bottom Line" yesterday, Ackman announced that he ...
 Motley Fool4 hours ago

Cancer unites AZ's MedImmune and Advaxis

Advaxis and MedImmune are collaborating on an immuno-oncology project to trial a potential cancer treatment. AstraZeneca's MedImmune the biologics research and development arm of the company has confirmed it is uniting with Advaxis on an ...
 Pharma Field4 hours ago MedImmune to work with biotech Advaxis on cancer  Pharmafocus7 hours ago

Cambridge Consultants, AstraZeneca launch BYDUREON Pen

To help in the treatment of type II diabetes Product design and development firm Cambridge Consultants has worked with AstraZeneca to develop BYDUREON Pen (exenatide extended-release for injectable suspension) 2 mg, which received US Food and Drug ...
 Express Pharma6 hours ago Cambridge Consultants & AstraZeneca develop Bydureon pen for type 2 diabetes  PharmaBiz5 days ago Innovative Pre-filled pen injector for adults with type 2 diabetes  India Infoline1 day ago

Neil Woodford's Risky Portfolio, ft. AstraZeneca plc And Imperial Tobacco Group PLC

AstraZeneca (LSE: AZN), BT Group (LSE: BT-A) , Rolls -Royce (LSE: RR)and Imperial Tobacco (LSE: IMT)account for about 23% of Neil Woodford's new equity portfolio. BAE Systems , Legal & General and Centrica make up for an additional 7%. Has Mr ...
 Yahoo! UK and Ireland8 hours ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - astrazeneca
Get updated on latest news & your favorite topics right in your inbox!
More     Less